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Abstract
Background:  In-vitro fertilization (IVF) has established its place in the management of  
infertility cases that has defied conventional treatment. A successful In-vitro fertilization 
outcome is based on a good ovarian response to gonadotrophin stimulation. Body mass index 
has been identified as one factor that can affect ovarian response however; there is no consensus 
about its impact outcome.
Objectives: To determine the effect of  body mass index (BMI) on ovarian response in an In-
vitro fertilization cycle.
Method: A Prospective cohort study to determine the response to Controlled Ovarian 
Hyperstimulation (COH) in women with normal and abnormal BMI in an IVF cycle. One 
hundred and four (104) consenting women undergoing non-donor IVF cycles in a university 
teaching hospital were recruited for the study.  Selected participants had their body mass indices 
(BMI) assessed and classified into 3 groups: Normal weight (18.5-24.9kg/m2), overweight (25-
29.9kg/m2) and obese (≥30kg/m2). There were no underweight women-BMI <18.5kg/m2. 
All the participants had Controlled Ovarian Hyperstimulation with the long agonist protocol. 
Selected participants had follicular count assessed using a transvaginal sonography on day 3, 5, 
10 and at retrieval. The effect of  ovarian response with the IVF treatment assessed based on 
total number of  follicles and oocyte yield on the day of  retrieval. 
Results: Female participants with normal weight women were thirty-six (34.6%), overweight 
were forty (38.5%) and obese, twenty-eight (26.9%). There was no statistical significant difference 
when the ages of  women at presentation, total gonadotrophins requirements, duration of  
stimulation and number of  oocytes retrieved were compared in the three groups.
Conclusion: Increase in body mass index does not appear to have an adverse effect on ovarian 
response in an In-vitro fertilization cycle.
_________________________________________________________________________
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Introduction
Infertility is a major public health challenge worldwide. 
In developing countries, a paradox of  infertility has been 
described whereby there is the presence of  an over-
population crisis in the background of  very high level of  
infertility constituting about 60% of  all gynaecological 
consultations.[1] This is however not very surprising, 
particularly in Africa, where very high premium is 
placed on childbirth and the inability to procreate have 
far reached effect at the individual, community and 
societal levels.[2, 3] The direct causes of  infertility in the 
female are many with the major contributors being tubal 
and endometrial problems as well as problems with 
ovulation. However, the effect of  these direct causative 
factors is strongly modified by biophysical factors 
particularly the age of  the woman and her body habitus. 
For an ovulation many contributors are recognized 
with notable factors being the age of  the woman, the 
presence of  the polycystic ovary syndrome (PCOS), 
endometriosis and obesity.[4–6] 
Overweight and Obesity, defined by the World Health 
Organization as body mass indices of  25.0-29.9 kg/m2 
and ≥30 kg/m2 respectively.[7] Elevated BMI can affect 
the outcome of  both conventional infertility management 
and assisted conception. Obesity is also associated with 
PCOS and is an important determinant of  response to 
conventional treatment. The polycystic ovary syndrome 
is a noted determinant of  IVF outcome and is presently 
the subject of  many researches. Both PCOS and obesity 
are associated with low fertility, menstrual disturbance 
and poor response both to ovulation induction during 
routine infertility treatment as well as during super-
ovulation required with assisted reproduction technology 
(ART). In ART, despite no consensus being reached, 
recent systematic reviews and retrospective studies with 
large sample sizes have highlighted a significant reduction 
https://dx.doi.org/10.4314/rjmhs.v2i1.3
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in implantation, pregnancy and life birth rates in obese 
women undergoing IVF.[8] In some study, overweight 
and obesity were associated with increased amount 
of  gonadotrophin use, decreased number of  oocyte 
retrieved, and increased cycle cancellation in IVF.[9]
The lack of  consensus on the impact of  BMI on 
ovarian response in an IVF cycle against a backdrop 
of  increasing prevalence of  women with elevated body 
mass indices presenting at the infertility clinic for IVF, 
necessitated the need to ascertain the impact body mass 
index has on ovarian response following routine long 
agonist protocol stimulation. Findings from the study 
can help improve fertility treatment and counselling. 
Methodology
Setting The study was conducted at the Human 
Reproduction and Research Programme (HRRP) Unit 
of  the Obstetrics and Gynaecology department of  the 
University of  Benin. The HRRP is a dedicated infertility 
management unit with Assisted Reproduction Technology 
(ART) services located within the teaching hospital 
complex. The ART services currently available in the 
centre include: intra-uterine insemination (IUI), in-vitro 
fertilization/embryo transfer (IVF/ET), intra-cytoplasmic 
sperm injection (ICSI) and cryopreservation of  embryos.
Study design It was a prospective cohort study over a 
5-month period (June 2013 to October 2013) inclusive 
of  all consenting female partners of  infertile couples 
with good ovarian reserve (Basal FSH ≤ 10IU/L) 
attending the infertility clinic at the University of  Benin 
Teaching Hospital, Benin city.
Exclusion Criteria:
1. Women whose ovaries could not be assessed by 
transvaginal ultrasonography.
2. Those who refused to give consent.
3. Women with basal FSH >10IU/L.
Methods A detailed history was taken as well as general 
and physical examination done for female partners of  
infertile couples attending the infertility clinic. Selected 
participants with basal follicle stimulating hormone (day 
3 of  the cycle) of  ≤10IU/L had their weight (kilogram), 
height (metre) and body mass indices (kilogram/metre2) 
measured. Based on their BMI they were classified 
into underweight (<18.5kg/m2), normal weight (18.5 – 
24.9kg/m2), overweight (25 – 29.9kg/m2) and obese (≥ 
30kg/m2). They all had the long as detailed below and 
transvaginal ultrasound assessment of  the follicles on 
day 3 prior to commencement of  stimulation, as well 
as on days 5, 8, 10 and the day of  egg retrieval. The 
number of  oocytes retrieved at retrieval was assessed.
Procedure Blood sample was collected for basal Follicle 
Stimulating Hormone (bFSH) prior to the treatment 
cycle in the early follicular phase (day 3) of  the cycle. 
Selected patients were commenced on combined oral 
contraceptive pill in order to synchronize their menses 
to the time scheduled for the IVF. Controlled Ovarian 
Hyperstimulation (COH) for all the patients was carried 
out using the long agonist protocol. First, the pituitary 
gland was down-regulated by daily subcutaneous 
injections of  0.5 mg of  Buserelin starting on day 21 
(mid-luteal phase) of  the synchronized menstrual 
cycle preceding the treatment cycle. Gonadotrophin 
suppression was assessed by transvaginal scan showing 
endometrial thickness <5mm and few or no antral 
follicles, or onset of  menstruation. The dose of  Buserelin 
was then reduced to 0.25mg per day on day 3 of  the new 
menstrual cycle at the commencement of  stimulation. 
Transvaginal scanning was also performed to determine 
the follicular count. The stimulation was effected by 
daily injections of  225-450IU of  highly purified Human 
Menopausal Gonadotrophin (MenopurR). The dose was 
adjusted depending on the age of  the patient as well 
as the ovarian response afterwards. Serial transvaginal 
scanning was done from day 5 to monitor ovarian 
response and the Menopur dose adjusted according 
to ovarian response. Cycles were cancelled when the 
follicles remained <10mm after 10 days of  stimulation. 
Intramuscular injections of  Human Chorionic 
Gonadotrophin (HCG) 10,000 IU were given when 
the leading follicles reached 18mm or more in diameter 
to effect the final maturation of  the follicles. Oocytes 
retrieval was subsequently performed 34-36 hours after 
HCG administration under ultrasound guidance. The 
numbers of  follicles aspirated and oocytes retrieved 
were carefully noted.
Outcome measures The primary outcome measure 
was the number of  oocytes retrieved following COH in 
women with normal and abnormal BMI. The secondary 
outcome measures were the total dose of  gonadotropins 
used, duration of  stimulation, presence of  ovarian 
hyperstimulation syndrome (OHSS) and cancellation rates.
Sample size Determination Orhue et al.[1] showed in 
Benin that 60% of  infertility cases may need assisted 
reproductive technology. Using the result of  the study, 
sample size calculation was done using the formula.[10]
               Ns= (Z/E)2P(1-P)
Where  Ns = the required sample size
Z = standard score corresponding to 
given confidence level-1.96
E = the proportion of  sample error in a 
given situation
P = the estimated proportion of  incidence 
of  cases in the population
Also, a confidence level of  95% is desired hence a 
tolerable error of  not greater than 0.1 is taken.
Hence, our sample size is:(Z/E)2P(1-P) = 
(1.96/0.10)20.6(1-0.6) = Ns = 92.198
With an attrition rate of  10%, the minimum sample size 
was 101. However, to broaden the base of  the study the 
total number of  women who met the criteria within the 
study period was used, hence a sample size of  104.
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Data Management Data entry and analysis were done 
using SPSS Statistical Software Version 20. Results were 
presented as means, standard deviations, frequencies 
and percentages. Statistical analysis of  generated data 
was calculated using the Chi-square test. Statistical 
significance was set as P ≤ 0.05.
Ethical Consideration Approval for the study was 
obtained from the Ethical and Research Committee of  
the University of  Benin Teaching Hospital. The study 
was carefully explained to the patients and informed 
consent obtained before being recruited into the study. 
Participation in this research was entirely voluntary. 
Participants were counselled that they could opt out 
of  the study at any time they so desired and it will not 
be held against them in any way, now or in future in 
their clinical management in the hospital or any of  its 
affiliated institutions.
Results
There were a total of  104 women recruited for the 
study. Those with normal weights were 36 (34.6%), 
overweight, 40 (38.5%) and obese, 28 (26.9%). There 
were no underweight patients (BMI <18.5kg/m2). Table 
1 shows that most of  the women recruited for the study 
were in the age group of  30-34 years (38.5%) and had 
primary infertility (83.7%). Majority of  participants 
(73.1%) had tertiary education. 
















































Table 2 shows the descriptive characteristics of  the participants during the study. It shows the participants in the 
various groups to be comparable in terms of  age, total dose of  gonadotrophins (Menopur) used and days of  
stimulation. The differences were not statistically significant (P>0.05).











Age (yrs) 31.94±6.99 32.98±3.98 35.14±5.69 0.080
Total dose of  Gonadotrophin used (IU) 3966.67±927.23 4222.50±1014.40 4307.14±874.51 0.314
Duration of  stimulation (days) 12.46±1.09 12.48±1.06 12.89±1.03 0.200
Values are expressed as Mean ± Standard Deviation
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Table 3 shows the mean follicle count on trans-vaginal scanning during stimulation, at follicle aspiration and eventual 
number of  oocytes retrieved was compared between groups. The differences in ovarian response on day 5 and 10 in 
terms of  the follicle count were statistically significant among the BMI groups. However, at retrieval, the follicular 
count and number of  oocytes retrieved were not statistically different amongst the groups with a P-value of  0.155 
and 0.193 respectively.
Table 3. BMI and COH response
Patient Type Normal BMI Overweight Obese p-value
Follicular Count  
Day 3 2.33±0.58 1.33±0.58 1.50±0.71 0.199
Day 5 9.83±5.81 7.85±4.95 6.22±4.04 0.021
Day 10 13.92±7.75 10.63±6.51 8.81±5.62 0.011
At Retrieval  
Follicular Count 10.25±3.93 9.58±5.29 7.88±5.05 0.155
Number of   oocytes 9.11±6.58 7.13±5.69 6.50±4.66 0.193
Values are expressed as Mean ± Standard Deviation 
Discussion
Ovarian response to stimulation can be affected by 
factors such as the woman’s age, BMI, the cause of  
the infertility amongst others. However, the effect 
of  BMI has not been clearly defined, with different 
authors reporting conflicting findings. This study 
showed that all three groups of  BMI were comparable 
in terms of  gonadotrophins requirements as well as 
duration of  stimulation. There were no cases of  ovarian 
hyperstimulation syndrome or cycle cancellation and 
the number of  oocytes retrieved was not significantly 
affected by the BMI of  participants.
In line with our study findings, Marci et al. [11] in a study 
of  ovarian stimulation in women with high and normal 
body mass index compared the long agonist protocol 
to the short antagonist protocol; reported no significant 
differences in the length of  stimulation, number of  
oocytes retrieved or number of  embryos transferred 
using either of  the protocols. This shows that the 
choice of  stimulation protocol does not significantly 
influence ovarian response. This buttresses the validity 
of  our study findings despite using only the long agonist 
protocol. 
Furthermore, we observed that the total dose of  
gonadotrophins as well as the days of  stimulation was 
comparable with BMI groups. Other studies also showed 
similar reports.[12–15] However, Maheshwari et al.[8] 
in a systematic review of  the effect of  overweight and 
obesity on assisted reproduction technology noted that 
statistically significant higher doses of  gonadotrophins 
were needed for ovulation induction in women with 
elevated BMI (BMI≥25kg/m2). They suggested a 
suspected phenomenon of  gonadotrophin resistance 
as BMI increases and consequently, longer periods of  
ovarian stimulation and higher cancellation rates. The 
findings in the study may be compromised by the fact 
that it was a systematic review of  studies which showed 
a variation in their choice of  subjects. Still contrary 
to our study findings, other researchers noted that 
with increasing BMI the number of  oocytes retrieved 
reduces.[8, 16]  Pinborg et al.[16] observed a reduction 
in the number of  oocytes retrieved as the BMI increases 
which was statistically significant (P<0.001).
In this study we demonstrated that the mean number of  
oocytes retrieved from women with normal BMI was 
more than that retrieved from those with elevated BMI 
but the difference was not statistically significant. This 
is similar to the reports of  other research work which 
show that the number of  retrieved oocytes, fertilization 
rate, embryo quality, dose of  gonadotrophins, number 
of  transferred and frozen embryos, hyperstimulation, 
pregnancy rates, miscarriage rates and live birth rates 
showed no statistically significant differences among 
BMI groups.[12, 14] They concluded that BMI did not 




Based on the findings from this study we can conclude 
that increase in body mass index does not appear to have 
an adverse effect on ovarian response amongst female 
partners of  infertile couples in an IVF cycle. There is 
however, no controversy that overweight and obesity 
have become major health concerns worldwide and the 
benefits of  weight control cannot be over emphasized. 
Female partners of  infertile couples with elevated 
BMI seeking IVF infertility treatment can be reassured 
that their BMI may not adversely affect their ovarian 
response as well as their quest for conception but overall 
obesity is discouraged for healthy living.
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